PUVA phototherapy-induced secondary amyloidosis in patients with mycosis fungoides: a rare adverse effect of phototherapy Itır

PUVA phototherapy-induced secondary amyloidosis in patients with mycosis fungoides: a rare adverse effect of phototherapy Itır

Aim: Amyloidosis is a common disorder in adults. Secondary amyloidosis in patients with mycosis fungoides (MF) after photochemotherapy with 8-methoxypsoralen followed by ultraviolet A (PUVA) treatment has not been reported. Our aim is to describe the clinical and histological features of PUVA phototherapy-induced secondary amyloidosis. Materials and methods: Sixty-one patients with MF treated with PUVA phototherapy were analyzed clinically and pathologically and by staining with Congo red and crystal violet. Results: Of 61 patients, 5 met the study criteria. Secondary amyloidosis was detected in 5 patients treated with PUVA. The secondary amyloidosis appeared after a mean of 56 exposures (range: 30 81) and a mean cumulative PUVA radiation dose of 131.7 J/cm2 (range: 31 305.5). The mean follow-up duration from the date of occurrence of the secondary amyloidosis was 18.2 weeks (range: 10 30). Histologically, vacuolar interface changes, colloid bodies, and melanophages were seen in all 5 patients. There were 4 patients who had perivascular lymphocytic infiltration and 1 patient had lichenoid lymphocytic infiltration. Conclusion: It should be noted that secondary amyloidosis can be present in patients who have been treated with PUVA therapy and it can be a result of the apoptotic effect of PUVA on the basal keratinocytes.

___

  • 1. Baron ED, Stevens SR. Phototherapy for cutaneous T-cell lymphoma. Dermatol Ther 2003; 16: 303–10.
  • 2 . Morita A, Werfel T, Stege H, Ahrens C. Evidence that singlet oxygen-induced human T-helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997; 186: 1763–8.
  • 3 . Nasser N, Sassevılle D. Amyloidosis. Dermatol Rounds 2005; 4: 3.
  • 4 . Buxbaum JN, Tagoe CE. The genetics of the amyloidoses. Ann Rev Med 2000; 51: 543–69.
  • 5 . Picken MM. The changing concepts of amyloid. Arch Pathol Lab Med 2001; 125: 38–43.
  • 6 . Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997; 337: 898–909.
  • 7 . Schreml S, Szeimies RM, Vogt T, Landthaler M, Schroeder J, Babilas P. Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement Eur J Dermatol 2010; 20: 152–60.
  • 8 . Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988; 18: 1–16.
  • 9 . Glenner GG. Amyloid deposits and amyloidosis. The betafibrilloses (first of two parts). N Engl J Med 1980; 302: 1283–92.
  • 10 . Kumakiri M, Hashimoto K. Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration. J Invest Dermatol 1979; 73: 150–62.
  • 11 . Li WM. Histopathology of primary cutaneous amyloidoses and systemic amyloidosis. Clin Dermatol 1990; 8: 30–5.
  • 12 . Brownstein MH, Helwig EB. Secondary systemic amyloidosis: analysis of the underlying disorders. South Med J 1971; 64: 491–6.
  • 13 . Hashimoto K, Brownstein MH. Localized amyloidosis in basal cell epitheliomas. Acta Derm Venereol 1973; 53: 331–9.
  • 14 . Hashimoto K, Kumakiri M. Colloid-amyloid bodies in PUVAtreated human psoriatic patients. J Invest Dermatol 1979; 72: 70–80.
  • 15 . MacDonald DM, Black MM. Secondary localized cutaneous amyloidosis in melanocytic naevi. Br J Dermatol 1980; 103: 553–6.
  • 16 . Powell AM, Albert S, Bhogal B, Black MM. Discoid lupus erythematosus with secondary amyloidosis. Br J Dermatol 2005; 153: 746–9.
  • 17 . Ramírez-Santos A, Suárez-Amor O, Pérez-Pérez L, Loureiro M, Peteiro C, Toribio J. Localized cutaneous amyloidosis secondary to porokeratosis: a retrospective histopathologic study of 30 patients. Actas Dermosifiliogr 2008; 99: 639–43 (article in Spanish with English abstract).
  • 18 . Johansen JD, Frosch PJ, Lepoıttenvın JP. Contact Dermatitis. Berlin: Springer; 2011. p.155–62
  • 19 . Dall’Acqua F, Vedaldi D, Bordin F, Rodighiero G. New studies on the interaction between 8-methoxypsoralen and DNA in vitro. J Invest Dermatol 1979; 73: 191–7.
  • 20 . Laskin JD, Lee E, Laskin DL, Gallo MA. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding. Proc Natl Acad Sci USA 1986; 83: 8211–5.
  • 21 . Zatebsku Z. Cell membrane, a target for PUVA therapy. J Photochem Photobiol B 1994; 23: 101–9.
  • 22 . Coven TR, Walters IB, Cardinale I, Krueger JG. PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis. Photodermatol Photoimmunol Photomed 1999; 15: 22–7.
  • 23 . Sontheimer RD. Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. J Invest Dermatol 2009; 129: 1088–99.
  • 24 . Karadağ AS, Güler Şimşek G. Familial amyloidosis cutis dyschromica. Turk J Med Sci 2010; 40: 151–4.
  • 25 . Chang YT, Liu HN, Wang WJ, Lee DD, Tsai SF. A study of cytokeratin profiles in localized cutaneous amyloids. Arch Dermatol Res 2004; 296: 83–8.
  • 26 . Miura Y, Harumiya S, Ono K, Fujimoto E. Galectin-7 and actin are components of amyloid deposit of localized cutaneous amyloidosis. Exp Dermatol 2013; 22: 36–40.
  • 27 . Hashimoto K, Ito K, Taniguchi Y, Yang F, Youngberg G. Keratin in cutaneous amyloidoses. Clin Dermatol 1990; 8: 55–65.
  • 28 . Grene I, Cox AJ. Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet light. Arch Dermatol 1979; 115: 1200–2.
  • 29 . Crowson AN, Magro CM. Recent advances in the pathology of cutaneous drug eruptions. Dermatol Clin 1999; 17: 537–60.
  • 30 . Epstein JH. Phototoxicity and photoallergy. Semin Cutan Med Surg 1999; 18: 274–84.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Acute Q fever among febrile patients in Zahedan, southeastern Iran

Maliheh METANAT, Nahid Sepehri RAD, Roya ALAVI-NAINI, Shahram SHAHREKI, Batool SHARIFI-MOOD, Aida AKHAVAN, Zahra POORMONTASERI

Incidental parathyroidectomy during thyroid surgery: risk factors, incidence, and outcomes

Bünyami ÖZOĞUL, Müfide Nuran AKÇAY, Abdullah KISAOĞLU

Single port thoracoscopic sympathectomy for primary palmar hyperhidrosis in adolescence

Nesimi GÜNAL, Berkant ÖZPOLAT, Yasemin Dere GÜNAL, Koray DURAL

Attachment style and perceived social support as predictors of biopsychosocial adjustment to cancer

Ayşe Gül YILMAZ ÖZPOLAT, Tuğba AYAZ, Özlem KONAĞ, Asiye ÖZKAN

Protective role of caffeic acid phenethyl ester on serum cholinesterase inhibition by acute exposure to diazinon in rats

Esin OĞUZHANOĞLU, Ahmet Cenk ANDAÇ, Adnan TÜFEK, Lütfi YAVUZ, Hüseyin VURAL, Osman GÖKALP

Increasing resistance of nosocomial Acinetobacter baumannii: are we going to be defeated?

Tümer GÜVEN, Gülruhsar YILMAZ, Hatice Rahmet GÜNER, Ayşe Kaya KALEM, Fatma ESER, Mehmet Akın TAŞYARAN

PUVA phototherapy-induced secondary amyloidosis in patients with mycosis fungoides: a rare adverse effect of phototherapy

İtır Ebru ZEMHERİ, Sıdıka Şeyma ÖZKANLI, İlkin ZİNDANCI, Serkan ŞENOL, Özge AKBULAK, Filiz Topaloğlu DEMİR

Choroidal thickness in healthy Turkish subjects

Erol COŞKUN, Seydi OKUMUŞ, Bülent GÜRLER, Ramazan YAYUSPAYI, Burak ÖREN, Erdal KAYDU, Ayşegül ÇÖMEZ, İbrahim ERBAĞCI

Comparison of the effects of different percutaneous tracheotomy techniques on acute tracheal trauma

Cengiz Bekir DEMİREL, Hacer HALTAŞ, Hasan Kutluk PAMPAL, Yusuf ÜNAL, Berrin IŞIK, Mükerrem UYSAL

Liver enzymes, mean platelet volume, and red cell distribution width in gestational diabetes

Serpil ERDOĞAN, Özhan ÖZDEMİR, Halef Okan DOĞAN, Sevilay SEZER, Cemal Reşat ATALAY, Fatma Meriç YILMAZ, Yüksel KOCA